JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Cost Analysis of Sunscreens Targeted Towards Skin of Color

Published online October 2, 2024

Skin cancer is the most common cancer diagnosis and there are several preventative measures aimed at reducing its prevalence such as ph...

read more
Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% Gel for Male and Female Acne: Phase 3 Analysis

Published online September 30, 2024

Acne is a chronic dermatologic condition affecting up to 50 million people in the United States annually. 1 Although acne afflicts bot...

read more
Primary Hyperhidrosis and Sensitive Skin: Exploring the Link with Predictive Machine Learning-Based Classification Models

Published online September 30, 2024

Primary hyperhidrosis (PHH) is the most common disease of the eccrine gland, and is characterized by excessive sweating due to elevate...

read more
A Novel Protection and Repair Skincare Regimen Shows Efficacy for Improving Environmental Skin Aging

Published online September 30, 2024

The skin is the most exposed organ to the environment. Solar radiation, pollutants, and fluctuations in temperature are all environment...

read more
A Consensus on Staphylococcus Aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment

Published online September 30, 2024

Current Clinical Challenges in Atopic Dermatitis Management and Treatment Despite advances in topical and systemic treatment options...

read more
Application Characteristics and Patient Preference of Triple-Combination vs Layered Topicals for Acne: Split-Face Study

Published online September 25, 2024

In the treatment of acne, therapies that address multiple pathophysiological pathways are recommended for most patients. 1 Combination...

read more
Hypochlorous Acid: A Blast from the Past

Published online September 24, 2024

Hypochlorous acid (HOCl) is one of the latest skincare ingredients to gain widespread popularity on social media. Despite newfound int...

read more
A Review of the Vitiligo Literature to Standardize Expression of Disease Severity

Published online September 20, 2024

There is a poor understanding at this time as to best- practice in recording outcomes in vitiligo. This is because there is an extremel...

read more
Reply to “The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers”

Published online September 19, 2024

We read with great interest the Cartwright et al paper "The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Ski...

read more
Opt for Methotrexate Before Biologics in the Treatment of Recalcitrant Delayed-Onset Reactions To Dermal Fillers

Published online September 19, 2024

To the Editor: We read with interest the case of a post-hyaluronic acid (HA) filler reaction treated with abrocitinib, a JAK inhibitor (JAKi)...

read more
Assessing Patient Preferences for Atopic Dermatitis Treatment: A Review Article of Discrete Choice Experiments

Published online September 17, 2024

Atopic dermatitis (AD) is one of the most prevalent inflammatory skin conditions, characterized by recurrent eczema with varying degree...

read more
Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema

Published online September 17, 2024

The role of the vehicle in topical prescription treatments is to deliver therapeutic concentrations of an active drug to a designated s...

read more
The ABCs of JAKis: A Clinician's Guide to Safety and Monitoring of the Systemic JAK Inhibitors

Published online September 16, 2024

Since the release of the first FDA-approved targeted biologic agent in 2017, several years have elapsed since a new systemic therapy ha...

read more
Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis

Published online December 31, 1969

read more
Treatment of Granuloma Annulare Using Tapinarof Cream 1%

Published online September 13, 2024

Granuloma annulare (GA) is a benign, non-infectious cutaneous granulomatous disease with an estimated prevalence of up to 0.06% in the ...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Journal of Drugs in Dermatology JDD article titled The ABCs of JAKis: A Clinician's Guide to Safety and Monitoring of the Systemic JAK Inhibitors

The ABCs of JAKis: A Clinician’s Guide to Safety and Monitoring of the Systemic JAK Inhibitors

| Featured Articles, The Latest | No Comments
JDD Article Highlight Curious about the latest in dermatology treatments? Janus Kinase Inhibitors (JAKis) are gaining traction as a powerful tool for various skin conditions—but there’s more to the story.…

Reface the Chase: Paradigm shifts in the AD Management Strategy Mentality

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Raj Chovatiya Who doesn't love a good game of "Whack a Mole?" Anyone? Just as you try to stay ahead of those furry, taunting, smiling devils…
Journal of Drugs in Dermatology JDD article about Minimizing Medical Error-Related Adverse Events With Platelet-Rich Plasma: A Protocolized Approach to Safety

Minimizing Medical Error-Related Adverse Events With Platelet-Rich Plasma: A Protocolized Approach to Safety

| Featured Articles, The Latest | No Comments
JDD Article Highlight Platelet-rich concentrates (PRCs) have become popular in dermatology for a variety of treatments, but recent reports link their use to blood-borne infections like HIV and hepatitis. While…
Journal of Drugs in Dermatology JDD article about Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists. The most frequent reactions were rash, pruritus, and alopecia. Links to Inclusive Derm Atlas for alopecia hair related pictures.

Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists

| Featured Articles, The Latest | No Comments
JDD Article Highlight

Dermatology Roundup: National Eczema Association Aims to Define “Flare”

| Atopic Dermatitis, Dermatology Roundup, JDD Highlights, JDD in the Media, The Latest | No Comments
By Allison Sit A National Eczema Association (NEA) study published in JAMA Dermatology identified patient-reported attributes associated with a “flare” of atopic dermatitis. The study sought to develop a clearer…

A Clinical Histology Study Evaluating the Biostimulatory Activity Longevity of Injectable Poly-L-Lactic Acid for Facial Rejuvenation

| Aesthetics, Featured Articles, The Latest | No Comments
JDD Article Highlight Curious about the latest on Poly-L-lactic acid (PLLA)? Read one of JDD’s latest articles titled “A Clinical Histology Study Evaluating the Biostimulatory Activity Longevity of Injectable Poly-L-Lactic Acid…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

From Cutaneous Microbiota to Clinical Trial Recruitment… Diversity Matters

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Zoe Draelos Unless you have been under a pile of retention hyperkeratosis, it would be hard to say one has not heard the call to purposefully…
Tune In

New CME Activities

Prevention is the Best Medicine: ADing up the Data

| Atopic Dermatitis, CME Activities, Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Candrice Heath, Dr. Jonathan O’B. Hourihane & Dr. Adam Friedman Continue to CME Activity Atopic Dermatitis (AD) is the second most common chronic inflammatory (coming for…
Explore CME

Follow Us